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Background
Hereditary angioedema (HAE) with normal C1 esterase
inhibitor (C1INH) was described for the first time in
2000. It was characterized by subcutaneous, gastrointest-
inal and laryngeal edema with familial history. Trigger-
ing factors are: stress, hormonal factors, trauma and
infections. The authors evaluate response to therapy in
patients with HAE without C1-INH deficiency.
Methods
It was analized therapeutical response to hereditary
angioedema without deficiency of C1INH. Patients with
clinical symptoms compatible with HAE have been
included after normal quantitative and functional
C1INH levels and positive family history for HAE, inde-
pendent of factor XII mutation.
Results
Nineteen patients have been identified (2M:17F; 20-60
years old). The following therapies were oriented: com-
bined contraceptive substitution for progestagen (10/19);
treatment with progestagen (2/19); tranexamic acid
(15/19): 1250mg (2), 1000mg (1), 750 (5), 500 mg (4),
250 mg (1); oxandrolon (5/19) (0.5 mg-5mg/day), danazol
200mg/day (1/19) and combined therapy woth oxandro-
lon and tranexamic acid in two patients. Icatibant was
used in seven patients with clinical improvement. One of
them reported increasing frequency of attacks after
repeated use of this drug. Two patients received fresh
frozen plasma during attacks with clinical improvement.
Conclusions
HAE without C1-INH deficiency has no established
treatment. Clinical improvement was evident with the
exclusion of combined contraceptives. The majority of
the patients presented clinical response to tranexamic
acid in variable doses. Icatibant was adequate for the
therapy of attacks.
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